Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Issuer Symbol
-
ZBIO on Nasdaq
Fairmount Funds Management LLC - trading volume in the past year for Zenas BioPharma, Inc.
Holdings reported by Fairmount Funds Management LLC for Zenas BioPharma, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2,209,025 |
$41,971,475 |
$19.00 |
07 Oct 2025 |
By Fairmount Healthcare Fund II L.P. |
|
|
| Stock Option (Right to Buy) |
18,500 |
|
|
10 Jun 2025 |
By Tomas Kiselak |
Common Stock |
|
Transactions reported by Fairmount Funds Management LLC for Zenas BioPharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.